Neurological adverse events associated with anti-tumor necrosis factor α treatment
- PMID: 20495815
- DOI: 10.1007/s00415-010-5591-7
Neurological adverse events associated with anti-tumor necrosis factor α treatment
Abstract
Anti-tumor necrosis factor alpha (TNF-alpha) drugs have been successfully used for the treatment of rheumatic autoimmune diseases including rheumatoid arthritis (RA), psoriatic arthritis, psoriasis, ankylosing spondylitis (AS), juvenile chronic arthritis, and Crohn's disease. However, they have been associated with different neurological disorders, including alterations of peripheral nerves, multiple sclerosis (MS), optic neuritis (ON) and acute transverse myelitis (ATM). This article reviews the most current aspect regarding neurological adverse events associated with anti-TNF-alpha drugs with emphasis on the possible explanations for this relation and the pathogenic mechanism of TNF-alpha in neurological disorders.
Comment in
-
Aseptic meningitis in a patient receiving treatment with anti-tumour necrosis factor alpha.J Neurol. 2011 Jun;258(6):1174-5. doi: 10.1007/s00415-010-5887-7. Epub 2010 Dec 31. J Neurol. 2011. PMID: 21193921 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous